The impact of hepatorenal syndrome and anemia on clinical outcomes

Jumayeva M.F

Klinik fanlar yilnomasi · 2025-yil

Annotatsiya

Hepatorenal syndrome (HRS) represents a severe complication in patients with advanced liver cirrhosis, characterized by rapid deterioration of renal function in the absence of structural kidney disease. While the pathophysiology of HRS has been extensively studied, the role of concomitant anemia as a potential prognostic factor remains inadequately characterized. This thesis investigates the relationship between anemia severity and clinical outcomes in patients with hepatorenal syndrome, examining both type 1 and type 2 HRS presentations. Through retrospective analysis of clinical data from 287 patients diagnosed with HRS between 2022-2024, this study evaluates hematological parameters, renal function markers, and survival outcomes. Results demonstrate that lower hemoglobin levels (<9 g/dL) are independently associated with increased 30-day mortality (HR 1.87, 95% CI 1.42-2.46, p<0.001) and reduced response to vasoconstrictor therapy. Furthermore, correction of anemia through targeted interventions was associated with improved renal recovery metrics. These findings establish anemia as a significant and potentially modifiable prognostic factor in HRS, suggesting that management protocols should incorporate hematological optimization alongside standard vasoconstrictive therapies to improve patient outcomes.

Maqola ma’lumotlari
MualliflarJumayeva M.F
JurnalKlinik fanlar yilnomasi
NashriyotБухоро давлат тиббиёт институти
ISSN2025-2026, 0009-0006
Nashr sanasi2025-08-12
Jild2
Son1
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-26

Maqolaning asl sahifasi

Kalit so‘zlar

Hepatorenal syndrome, analysis and results, Гепаторенальный синдром, анализ и результаты, Gepatorenal sindrom, tahlil va natijalar

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAJumayeva M.F (2025). THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES. Klinik fanlar yilnomasi, 2(1). https://tadqiqot.uz/index.php/spjacd/article/view/12075
GOST (OAK)Jumayeva M.F THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES // Klinik fanlar yilnomasi. – 2025. – T. 2, № 1.
MLAJumayeva M.F. “THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES.” Klinik fanlar yilnomasi, 2(1), 2025. https://tadqiqot.uz/index.php/spjacd/article/view/12075
ChicagoJumayeva M.F. “THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES.” Klinik fanlar yilnomasi, 2(1) (2025). https://tadqiqot.uz/index.php/spjacd/article/view/12075
HarvardJumayeva M.F (2025) ‘THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES’, Klinik fanlar yilnomasi, 2(1). https://tadqiqot.uz/index.php/spjacd/article/view/12075
BibTeX
@article{jumayevamf2025,
  title = {THE IMPACT OF HEPATORENAL SYNDROME AND ANEMIA ON CLINICAL OUTCOMES},
  author = {Jumayeva M.F},
  journal = {Klinik fanlar yilnomasi},
  year = {2025},
  volume = {2},
  number = {1},
  url = {https://tadqiqot.uz/index.php/spjacd/article/view/12075}
}

Boshqa maqola uchun iqtibos tayyorlash

Klinik fanlar yilnomasi jurnalidan boshqa maqolalar

Klinik fanlar yilnomasi — barcha maqolalar · 2025-yil arxivi

Jumayeva M.F — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari